Literature DB >> 9772287

Brain-specific angiogenesis inhibitor 1 expression is inversely correlated with vascularity and distant metastasis of colorectal cancer.

Y Fukushima1, Y Oshika, T Tsuchida, T Tokunaga, H Hatanaka, H Kijima, H Yamazaki, Y Ueyama, N Tamaoki, M Nakamura.   

Abstract

Brain-specific angiogenesis inhibitor (BAI) 1 was recently isolated as a novel p53 inducible gene. BAI1 has been suggested to play a significant role in angiostasis. We studied the expression of BAI1 in 49 colorectal cancer specimens by RT-PCR. BAI1 expression was significantly reduced in colorectal cancers as compared to the extraneoplastic tissues (X(2) test, p=0.041). BAI1 expression was inversely correlated with vascular invasion and metastasis (Fisher's exact test, p 0.045). Moreover, vascularity in the colorectal cancer was inversely correlated with BAI1 gene expression (Mann-Whitney U-test, p=0.0003). These observations suggested that BAI1 expression might inhibit angiogenesis and metastasis of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9772287     DOI: 10.3892/ijo.13.5.967

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  26 in total

Review 1.  Adhesion G Protein-Coupled Receptors: From In Vitro Pharmacology to In Vivo Mechanisms.

Authors:  Kelly R Monk; Jörg Hamann; Tobias Langenhan; Saskia Nijmeijer; Torsten Schöneberg; Ines Liebscher
Journal:  Mol Pharmacol       Date:  2015-05-08       Impact factor: 4.436

2.  From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders.

Authors:  Ariel F Martinez; Maximilian Muenke; Mauricio Arcos-Burgos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-12       Impact factor: 3.568

3.  The cell-adhesion G protein-coupled receptor BAI3 is a high-affinity receptor for C1q-like proteins.

Authors:  Marc F Bolliger; David C Martinelli; Thomas C Südhof
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-24       Impact factor: 11.205

4.  Antitumor efficacy of 34.5ENVE: a transcriptionally retargeted and "Vstat120"-expressing oncolytic virus.

Authors:  Ji Young Yoo; Amy Haseley; Anna Bratasz; E Antonio Chiocca; Jianying Zhang; Kimerly Powell; Balveen Kaur
Journal:  Mol Ther       Date:  2011-10-25       Impact factor: 11.454

5.  BAI1 Orchestrates Macrophage Inflammatory Response to HSV Infection-Implications for Oncolytic Viral Therapy.

Authors:  Chelsea Bolyard; W Hans Meisen; Yeshavanth Banasavadi-Siddegowda; Jayson Hardcastle; Ji Young Yoo; Eric S Wohleb; Jeffrey Wojton; Jun-Ge Yu; Samuel Dubin; Maninder Khosla; Bo Xu; Jonathan Smith; Christopher Alvarez-Breckenridge; Pete Pow-Anpongkul; Flavia Pichiorri; Jianying Zhang; Matthew Old; Dan Zhu; Erwin G Van Meir; Jonathan P Godbout; Michael A Caligiuri; Jianhua Yu; Balveen Kaur
Journal:  Clin Cancer Res       Date:  2016-11-09       Impact factor: 12.531

Review 6.  The Emerging Role of Adhesion GPCRs in Cancer.

Authors:  Abanoub A Gad; Nariman Balenga
Journal:  ACS Pharmacol Transl Sci       Date:  2020-01-13

Review 7.  Adhesion GPCRs in Tumorigenesis.

Authors:  Gabriela Aust; Dan Zhu; Erwin G Van Meir; Lei Xu
Journal:  Handb Exp Pharmacol       Date:  2016

8.  Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism.

Authors:  Balveen Kaur; Sarah M Cork; Eric M Sandberg; Narra S Devi; Zhaobin Zhang; Philip A Klenotic; Maria Febbraio; Hyunsuk Shim; Hui Mao; Carol Tucker-Burden; Roy L Silverstein; Daniel J Brat; Jeffrey J Olson; Erwin G Van Meir
Journal:  Cancer Res       Date:  2009-01-27       Impact factor: 12.701

Review 9.  Anti-angiogenic gene therapy in the treatment of malignant gliomas.

Authors:  NaTosha N Gatson; E Antonio Chiocca; Balveen Kaur
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

10.  Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1.

Authors:  Jayson Hardcastle; Kazuhiko Kurozumi; Nina Dmitrieva; Martin P Sayers; Sarwat Ahmad; Peter Waterman; Ralph Weissleder; E Antonio Chiocca; Balveen Kaur
Journal:  Mol Ther       Date:  2009-10-20       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.